Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ginoxil** is a line of topical intimate hygiene products, including protective moisturizing soothing gel, vaginal wash, ecofoam, and lotion, formulated for external use on sensitive and irritated genital areas. It contains active ingredients such as **zinc gluconate**, **taurine**, and **Hamamelis virginiana** (witch hazel), which provide antiseptic, anti-inflammatory, antioxidant, and haemostatic effects to prevent and treat minor skin infections, reduce vaginal infections, restore mucosal integrity, prevent ulcers, and alleviate irritation from drug therapies, menstrual periods, tampons, or bacterial imbalances while maintaining normal pH.[1][2][3][4][5][6][7][8][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ginoxil.